Literature DB >> 18936187

Rapid depletion of free vancomycin in medium in the presence of beta-lactam antibiotics and growth restoration in Staphylococcus aureus strains with beta-lactam-induced vancomycin resistance.

Chie Yanagisawa1, Hideaki Hanaki, Hidehito Matsui, Shinsuke Ikeda, Taiji Nakae, Keisuke Sunakawa.   

Abstract

A class of methicillin-resistant Staphylococcus aureus strains shows vancomycin resistance in the presence of beta-lactam antibiotics (beta-lactam-induced VAN-resistant methicillin-resistant S. aureus [BIVR]). Two possible explanations may be offered: (i) vancomycin in culture medium is depleted, and (ii) the D-Ala-D-Ala terminal of the peptidoglycan network is replaced with D-Ala-D-lactate. We tested these hypotheses by quantifying free vancomycin in the medium through the course of cell growth and by PCR amplification of the van genes. Growth of the BIVR cells to an absorption level of approximately 0.3 at 578 nm required about 24 h in the presence of vancomycin alone at the MIC (4.0 microg/ml). However, growth was achieved in only about 10 h when 1/1,000 to 1/2,000 the MIC of beta-lactam antibiotic was added 2 h prior to the addition of vancomycin, suggesting that the beta-lactams shortened the time to recovery from vancomycin-mediated growth inhibition. Free vancomycin in the culture medium decreased to 2.3 microg/ml in the first 8 h in the culture containing vancomycin alone, yet cell growth was undetectable. When the vancomycin concentration dropped below approximately 1.5 microg/ml at 24 h, the cells began to grow. In the culture supplemented with the beta-lactam 2 h prior to the addition of vancomycin, the drug concentration continuously dropped from 4 to 0.5 microg/ml in the first 8 h, and the cells began to grow at a vancomycin concentration of approximately 1.7 microg/ml or at 4 h of incubation. The gene encoding the enzyme involved in D-Ala-D-lactate synthesis was undetectable. Based on these results, we concluded that BIVR is attributable mainly to a rapid depletion of vancomycin in the medium triggered or promoted by beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936187      PMCID: PMC2612165          DOI: 10.1128/AAC.00762-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  K Totsuka; M Shiseki; K Kikuchi; Y Matsui
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

2.  Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR).

Authors:  H Hanaki; Y Yamaguchi; K Barata; H Sakai; K Sunakawa
Journal:  Int J Antimicrob Agents       Date:  2004-03       Impact factor: 5.283

Review 3.  Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus.

Authors:  Anne Tristan; Tristan Ferry; Geraldine Durand; Olivier Dauwalder; Michele Bes; Gerard Lina; François Vandenesch; Jerome Etienne
Journal:  J Hosp Infect       Date:  2007-06       Impact factor: 3.926

4.  Guidelines for the control of methicillin-resistant Staphylococcus aureus.

Authors:  A P Fraise
Journal:  J Antimicrob Chemother       Date:  1998-09       Impact factor: 5.790

5.  Pharmacia Biotech & Science prize. 1997 grand prize winner. Life in the balance: cell walls and antibiotic resistance.

Authors:  C Jacobs
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

6.  Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

Authors:  H Hanaki; K Kuwahara-Arai; S Boyle-Vavra; R S Daum; H Labischinski; K Hiramatsu
Journal:  J Antimicrob Chemother       Date:  1998-08       Impact factor: 5.790

7.  Investigation of methicillin-resistant Staphylococcus aureus showing reduced vancomycin susceptibility isolated from a patient with infective endocarditis.

Authors:  Yoko Takayama; Hideaki Hanaki; Kazuhiko Irinoda; Hideya Kokubun; Kazunari Yoshida; Keisuke Sunakawa
Journal:  Int J Antimicrob Agents       Date:  2003-12       Impact factor: 5.283

8.  Vancomycin-resistant Staphylococcus aureus--New York, 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-04-23       Impact factor: 17.586

9.  Staphylococcus aureus resistant to vancomycin--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-07-05       Impact factor: 17.586

10.  Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  6 in total

Review 1.  Messenger functions of the bacterial cell wall-derived muropeptides.

Authors:  Marc A Boudreau; Jed F Fisher; Shahriar Mobashery
Journal:  Biochemistry       Date:  2012-03-27       Impact factor: 3.162

Review 2.  Bacterial cell-wall recycling.

Authors:  Jarrod W Johnson; Jed F Fisher; Shahriar Mobashery
Journal:  Ann N Y Acad Sci       Date:  2012-11-16       Impact factor: 5.691

3.  Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.

Authors:  Xuting Zheng; Andrew D Berti; Sue McCrone; Melanie Roch; Adriana E Rosato; Warren E Rose; Baiyi Chen
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus.

Authors:  Diane C Broussou; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

5.  Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance.

Authors:  Yuriko Hirao; Yurika Ikeda-Dantsuji; Hidehito Matsui; Masaki Yoshida; Seiji Hori; Keisuke Sunakawa; Taiji Nakae; Hideaki Hanaki
Journal:  BMC Microbiol       Date:  2012-05-08       Impact factor: 3.605

6.  Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model.

Authors:  Diane C Broussou; Marlène Z Lacroix; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.